Modulight Biotherapeutics

Developer of an optogenetic platform targeting pathological neural activity to restore balance

placeBoston, Massachusetts, United States calendar_todayFounded 2022 language modulight.bio

Social engagement

Social engagement: 1.3K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Jibe Ventures, LocalGlobe.

Investor typeCountShare
Venture capital788%
Other / undisclosed113%

Recent activity

4 May 2026
Event
Biomed Israel 2026
3 May 2026
Leadership hire
expert advisor
28 Apr 2026
Recognition
Coming soon